{"transactions":[{"id":692927,"issuer":{"id":6916,"kind":"organization","name":"OKYO Pharma Ltd"},"owners":[{"id":25396,"kind":"person","name":"BRANCACCIO JOHN P","position":1,"cik":"0001276551","reported_name":"BRANCACCIO JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2026-08-07T20:15:38.000Z","date":"2026-07-21","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":1.477,"value":7385.0,"ownership":{"direct":true},"balance_after":35201,"source":{"system":"sec-edgar","filing":"0001493152-26-036585","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1276551/000149315226036585/ownership.xml","form_type":"4/A","original_submission_date":"2026-07-23"}},{"id":703959,"issuer":{"id":6916,"kind":"organization","name":"OKYO Pharma Ltd"},"owners":[{"id":25396,"kind":"person","name":"BRANCACCIO JOHN P","position":1,"cik":"0001276551","reported_name":"BRANCACCIO JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2026-07-23T20:15:24.000Z","date":"2026-07-21","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":1.477,"value":7385.0,"ownership":{"direct":true},"balance_after":35201,"source":{"system":"sec-edgar","filing":"0001493152-26-034405","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1276551/000149315226034405/ownership.xml","form_type":"4"}},{"id":742891,"issuer":{"id":6916,"kind":"organization","name":"OKYO Pharma Ltd"},"owners":[{"id":25396,"kind":"person","name":"BRANCACCIO JOHN P","position":1,"cik":"0001276551","reported_name":"BRANCACCIO JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option","published_at":"2026-06-10T21:00:05.000Z","date":"2026-06-08","kind":"grant","planned":false,"acquired":true,"shares":6500,"price":1.85,"value":12025.0,"ownership":{"direct":true},"balance_after":138394,"derivative":{"exercise_price":1.85,"exercise_date":"2027-06-08","expiration_date":"2036-06-08","underlying":"Common Shares","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001493152-26-028133","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1276551/000149315226028133/ownership.xml","form_type":"4"}},{"id":1628443,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":25396,"kind":"person","name":"BRANCACCIO JOHN P","position":1,"cik":"0001276551","reported_name":"BRANCACCIO JOHN P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman"}}],"security":"Stock Options","published_at":"2024-02-22T01:01:32.000Z","date":"2024-02-19","kind":"grant","planned":false,"acquired":true,"shares":85000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":99563,"derivative":{"exercise_price":2.56,"exercise_date":"2024-02-19","expiration_date":"2034-02-19","underlying":"Common Stock","underlying_shares":85000},"source":{"system":"sec-edgar","filing":"0001493152-24-007463","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1276551/000149315224007463/ownership.xml","form_type":"4"}},{"id":1772055,"issuer":{"id":6916,"kind":"organization","name":"OKYO Pharma Ltd"},"owners":[{"id":25396,"kind":"person","name":"BRANCACCIO JOHN P","position":1,"cik":"0001276551","reported_name":"BRANCACCIO JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-09-28T10:15:12.000Z","date":"2023-09-15","kind":"purchase","planned":false,"acquired":true,"shares":16670,"price":1.5,"value":25005.0,"ownership":{"direct":true},"balance_after":16670,"source":{"system":"sec-edgar","filing":"0001493152-23-034486","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1276551/000149315223034486/ownership.xml","form_type":"4"}},{"id":2237471,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":25396,"kind":"person","name":"BRANCACCIO JOHN P","position":1,"cik":"0001276551","reported_name":"BRANCACCIO JOHN P","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director"}}],"security":"Stock Options","published_at":"2022-06-09T23:48:59.000Z","date":"2022-06-09","kind":"other","acquired":true,"shares":195,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Expiration date of the stock options was extended to June 9, 2024."}],"balance_after":125317,"derivative":{"exercise_price":316.08,"exercise_date":"2014-12-11","expiration_date":"2024-06-09","underlying":"Common Stock","underlying_shares":195},"source":{"system":"sec-edgar","filing":"0001628280-22-016731","document":"wf-form4_165481851971252.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000162828022016731/wf-form4_165481851971252.xml","form_type":"4"}},{"id":2237470,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":25396,"kind":"person","name":"BRANCACCIO JOHN P","position":1,"cik":"0001276551","reported_name":"BRANCACCIO JOHN P","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director"}}],"security":"Stock Options","published_at":"2022-06-09T23:48:59.000Z","date":"2022-06-09","kind":"other","acquired":true,"shares":223,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Expiration date of the stock options was extended to June 9, 2024."}],"balance_after":125317,"derivative":{"exercise_price":516.96,"exercise_date":"2016-03-17","expiration_date":"2024-06-09","underlying":"Common Stock","underlying_shares":223},"source":{"system":"sec-edgar","filing":"0001628280-22-016731","document":"wf-form4_165481851971252.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000162828022016731/wf-form4_165481851971252.xml","form_type":"4"}},{"id":2237469,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":25396,"kind":"person","name":"BRANCACCIO JOHN P","position":1,"cik":"0001276551","reported_name":"BRANCACCIO JOHN P","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director"}}],"security":"Stock Options","published_at":"2022-06-09T23:48:59.000Z","date":"2022-06-09","kind":"other","acquired":true,"shares":223,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Expiration date of the stock options was extended to June 9, 2024."}],"balance_after":125317,"derivative":{"exercise_price":372.96,"exercise_date":"2017-01-04","expiration_date":"2024-06-09","underlying":"Common Stock","underlying_shares":223},"source":{"system":"sec-edgar","filing":"0001628280-22-016731","document":"wf-form4_165481851971252.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000162828022016731/wf-form4_165481851971252.xml","form_type":"4"}},{"id":2237468,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":25396,"kind":"person","name":"BRANCACCIO JOHN P","position":1,"cik":"0001276551","reported_name":"BRANCACCIO JOHN P","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director"}}],"security":"Stock Options","published_at":"2022-06-09T23:48:59.000Z","date":"2022-06-09","kind":"other","acquired":true,"shares":530,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Expiration date of the stock options was extended to June 9, 2024."}],"balance_after":125317,"derivative":{"exercise_price":51.84,"exercise_date":"2018-10-04","expiration_date":"2024-06-09","underlying":"Common Stock","underlying_shares":530},"source":{"system":"sec-edgar","filing":"0001628280-22-016731","document":"wf-form4_165481851971252.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000162828022016731/wf-form4_165481851971252.xml","form_type":"4"}},{"id":2237467,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":25396,"kind":"person","name":"BRANCACCIO JOHN P","position":1,"cik":"0001276551","reported_name":"BRANCACCIO JOHN P","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director"}}],"security":"Stock Options","published_at":"2022-06-09T23:48:59.000Z","date":"2022-06-09","kind":"other","acquired":true,"shares":755,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Expiration date of the stock options was extended to June 9, 2024."}],"balance_after":125317,"derivative":{"exercise_price":21.6,"exercise_date":"2019-01-23","expiration_date":"2024-06-09","underlying":"Common Stock","underlying_shares":755},"source":{"system":"sec-edgar","filing":"0001628280-22-016731","document":"wf-form4_165481851971252.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000162828022016731/wf-form4_165481851971252.xml","form_type":"4"}},{"id":2237466,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":25396,"kind":"person","name":"BRANCACCIO JOHN P","position":1,"cik":"0001276551","reported_name":"BRANCACCIO JOHN P","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director"}}],"security":"Stock Options","published_at":"2022-06-09T23:48:59.000Z","date":"2022-06-09","kind":"other","acquired":true,"shares":44734,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Expiration date of the stock options was extended to June 9, 2024."}],"balance_after":125317,"derivative":{"exercise_price":2.48,"exercise_date":"2020-06-20","expiration_date":"2024-06-09","underlying":"Common Stock","underlying_shares":44734},"source":{"system":"sec-edgar","filing":"0001628280-22-016731","document":"wf-form4_165481851971252.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000162828022016731/wf-form4_165481851971252.xml","form_type":"4"}},{"id":2237465,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":25396,"kind":"person","name":"BRANCACCIO JOHN P","position":1,"cik":"0001276551","reported_name":"BRANCACCIO JOHN P","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director"}}],"security":"Stock Options","published_at":"2022-06-09T23:48:59.000Z","date":"2022-06-09","kind":"other","acquired":true,"shares":28858,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Expiration date of the stock options was extended to June 9, 2024."}],"balance_after":125317,"derivative":{"exercise_price":2.6,"exercise_date":"2021-06-17","expiration_date":"2024-06-09","underlying":"Common Stock","underlying_shares":28858},"source":{"system":"sec-edgar","filing":"0001628280-22-016731","document":"wf-form4_165481851971252.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000162828022016731/wf-form4_165481851971252.xml","form_type":"4"}},{"id":2237464,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":25396,"kind":"person","name":"BRANCACCIO JOHN P","position":1,"cik":"0001276551","reported_name":"BRANCACCIO JOHN P","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director"}}],"security":"Stock Options","published_at":"2022-06-09T23:48:59.000Z","date":"2022-06-09","kind":"other","acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"In connection with the Reporting Person's departure from the Board of Directors, the Compensation Committee accelerated the vesting of 22,000 stock options to June 9, 2022 from June 10, 2022. In addition, the Compensation Committee extended the expiration date of the stock options to June 9, 2024."}],"balance_after":125317,"derivative":{"exercise_price":7.98,"exercise_date":"2022-06-09","expiration_date":"2024-06-09","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001628280-22-016731","document":"wf-form4_165481851971252.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000162828022016731/wf-form4_165481851971252.xml","form_type":"4"}},{"id":2237463,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":25396,"kind":"person","name":"BRANCACCIO JOHN P","position":1,"cik":"0001276551","reported_name":"BRANCACCIO JOHN P","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director"}}],"security":"Stock Options","published_at":"2022-06-09T23:48:59.000Z","date":"2022-06-09","kind":"other","acquired":true,"shares":26800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"In connection with the Reporting Person's departure from the Board of Directors, the Compensation Committee accelerated the vesting of 26,800 stock options to June 9, 2022 from March 9, 2023. In addition, the Compensation Committee extended the expiration date of the stock options to June 9, 2024."}],"balance_after":125317,"derivative":{"exercise_price":2.5,"exercise_date":"2022-06-09","expiration_date":"2024-06-09","underlying":"Common Stock","underlying_shares":26800},"source":{"system":"sec-edgar","filing":"0001628280-22-016731","document":"wf-form4_165481851971252.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000162828022016731/wf-form4_165481851971252.xml","form_type":"4"}},{"id":2339539,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":25396,"kind":"person","name":"BRANCACCIO JOHN P","position":1,"cik":"0001276551","reported_name":"BRANCACCIO JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2022-03-10T23:38:47.000Z","date":"2022-03-09","kind":"grant","acquired":true,"shares":26800,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":125317,"derivative":{"exercise_price":2.5,"exercise_date":"2023-03-09","expiration_date":"2032-03-09","underlying":"Common Stock","underlying_shares":26800},"source":{"system":"sec-edgar","filing":"0001628280-22-005789","document":"wf-form4_164695550374678.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000162828022005789/wf-form4_164695550374678.xml","form_type":"4"}},{"id":2669858,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":25396,"kind":"person","name":"BRANCACCIO JOHN P","position":1,"cik":"0001276551","reported_name":"BRANCACCIO JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2021-06-14T20:11:30.000Z","date":"2021-06-10","kind":"grant","acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":98517,"derivative":{"exercise_price":7.98,"exercise_date":"2022-06-10","expiration_date":"2031-06-10","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001628280-21-012171","document":"wf-form4_162370147280131.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000162828021012171/wf-form4_162370147280131.xml","form_type":"4"}},{"id":2702674,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":25396,"kind":"person","name":"BRANCACCIO JOHN P","position":1,"cik":"0001276551","reported_name":"BRANCACCIO JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2021-05-20T20:34:50.000Z","date":"2021-05-18","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Stock Options have been granted subject to stockholder approval of an increase in the shares of common stock issuable pursuant to the 2013 Equity Incentive Plan."}],"balance_after":291332,"derivative":{"exercise_price":1.7,"exercise_date":"2022-05-18","expiration_date":"2031-05-18","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001104659-21-069936","document":"tm2117144d3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1276551/000110465921069936/tm2117144d3_4seq1.xml","form_type":"4"}},{"id":2776099,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":25396,"kind":"person","name":"BRANCACCIO JOHN P","position":1,"cik":"0001276551","reported_name":"BRANCACCIO JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-22T22:35:38.000Z","date":"2021-03-22","kind":"purchase","acquired":true,"shares":3000,"price":10.95,"value":32850.0,"ownership":{"direct":true},"balance_after":12260,"source":{"system":"sec-edgar","filing":"0001628280-21-005297","document":"wf-form4_161645252417136.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000162828021005297/wf-form4_161645252417136.xml","form_type":"4"}},{"id":2960321,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":25396,"kind":"person","name":"BRANCACCIO JOHN P","position":1,"cik":"0001276551","reported_name":"BRANCACCIO JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-02T23:05:24.000Z","date":"2020-12-02","kind":"purchase","acquired":true,"shares":7000,"price":1.53,"value":10710.0,"ownership":{"direct":true},"balance_after":7008,"source":{"system":"sec-edgar","filing":"0001104659-20-131656","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1276551/000110465920131656/a4.xml","form_type":"4"}},{"id":3049712,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":25396,"kind":"person","name":"BRANCACCIO JOHN P","position":1,"cik":"0001276551","reported_name":"BRANCACCIO JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2020-08-21T20:16:28.000Z","date":"2020-08-19","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":91332,"derivative":{"exercise_price":3.72,"exercise_date":"2021-08-19","expiration_date":"2030-08-19","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001104659-20-097596","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1276551/000110465920097596/a4.xml","form_type":"4"}},{"id":3104080,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":25396,"kind":"person","name":"BRANCACCIO JOHN P","position":1,"cik":"0001276551","reported_name":"BRANCACCIO JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2020-06-19T20:16:34.000Z","date":"2020-06-17","kind":"grant","acquired":true,"shares":28858,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":76517,"derivative":{"exercise_price":2.6,"exercise_date":"2021-06-17","expiration_date":"2030-06-17","underlying":"Common Stock","underlying_shares":28858},"source":{"system":"sec-edgar","filing":"0001104659-20-075238","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000110465920075238/a4.xml","form_type":"4"}},{"id":3145142,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":25396,"kind":"person","name":"BRANCACCIO JOHN P","position":1,"cik":"0001276551","reported_name":"BRANCACCIO JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-18T20:16:49.000Z","date":"2020-05-14","kind":"purchase","acquired":true,"shares":6993,"price":1.43,"value":9999.99,"ownership":{"direct":true},"balance_after":9260,"source":{"system":"sec-edgar","filing":"0001104659-20-063179","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000110465920063179/a4.xml","form_type":"4"}},{"id":3180438,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":25396,"kind":"person","name":"BRANCACCIO JOHN P","position":1,"cik":"0001276551","reported_name":"BRANCACCIO JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2020-04-07T20:14:11.000Z","date":"2020-04-03","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":61275,"derivative":{"exercise_price":1.63,"exercise_date":"2021-04-03","expiration_date":"2030-04-03","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001104659-20-044171","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1276551/000110465920044171/a4.xml","form_type":"4"}},{"id":3455845,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":25396,"kind":"person","name":"BRANCACCIO JOHN P","position":1,"cik":"0001276551","reported_name":"BRANCACCIO JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2019-07-25T20:16:06.000Z","date":"2019-07-24","kind":"grant","acquired":true,"shares":970,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1275,"derivative":{"exercise_price":3.24,"exercise_date":"2019-07-24","expiration_date":"2029-07-24","underlying":"Common Stock","underlying_shares":970},"source":{"system":"sec-edgar","filing":"0001104659-19-041849","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1276551/000110465919041849/a4.xml","form_type":"4"}},{"id":3479879,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":25396,"kind":"person","name":"BRANCACCIO JOHN P","position":1,"cik":"0001276551","reported_name":"BRANCACCIO JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2019-06-24T20:05:36.000Z","date":"2019-06-20","kind":"grant","acquired":true,"shares":44734,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":47806,"derivative":{"exercise_price":2.48,"exercise_date":"2020-06-20","expiration_date":"2029-06-20","underlying":"Common Stock","underlying_shares":44734},"source":{"system":"sec-edgar","filing":"0000899243-19-017915","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000089924319017915/doc4.xml","form_type":"4"}},{"id":3871675,"issuer":{"id":164269,"kind":"organization","name":"SYNERGY PHARMACEUTICALS, INC.","symbol":"SGYP"},"owners":[{"id":25396,"kind":"person","name":"BRANCACCIO JOHN P","position":1,"cik":"0001276551","reported_name":"BRANCACCIO JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2018-07-06T20:31:02.000Z","date":"2018-07-04","kind":"exercise","acquired":false,"shares":50023,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options became exercisable on 7/9/2009 and 7/9/2010."}],"balance_after":506173,"derivative":{"exercise_price":0.5,"expiration_date":"2018-07-09","underlying":"Common Stock","underlying_shares":50023},"source":{"system":"sec-edgar","filing":"0001104659-18-044167","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1276551/000110465918044167/a4.xml","form_type":"4"}},{"id":3871674,"issuer":{"id":164269,"kind":"organization","name":"SYNERGY PHARMACEUTICALS, INC.","symbol":"SGYP"},"owners":[{"id":25396,"kind":"person","name":"BRANCACCIO JOHN P","position":1,"cik":"0001276551","reported_name":"BRANCACCIO JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-06T20:31:02.000Z","date":"2018-07-04","kind":"tax_withholding","acquired":false,"shares":13896,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares forfeited to the Company in payment of the exercise price of the stock options."}],"balance_after":116571,"source":{"system":"sec-edgar","filing":"0001104659-18-044167","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1276551/000110465918044167/a4.xml","form_type":"4"}},{"id":3871673,"issuer":{"id":164269,"kind":"organization","name":"SYNERGY PHARMACEUTICALS, INC.","symbol":"SGYP"},"owners":[{"id":25396,"kind":"person","name":"BRANCACCIO JOHN P","position":1,"cik":"0001276551","reported_name":"BRANCACCIO JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-06T20:31:02.000Z","date":"2018-07-04","kind":"exercise","acquired":true,"shares":50023,"price":0.5,"value":25011.5,"ownership":{"direct":true},"balance_after":130467,"source":{"system":"sec-edgar","filing":"0001104659-18-044167","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1276551/000110465918044167/a4.xml","form_type":"4"}},{"id":3874334,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":25396,"kind":"person","name":"BRANCACCIO JOHN P","position":1,"cik":"0001276551","reported_name":"BRANCACCIO JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants","published_at":"2018-07-03T18:16:44.000Z","date":"2018-07-03","kind":"purchase","acquired":true,"shares":1725,"price":1000,"value":1725000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Shares of Series C Convertible Preferred Stock and Warrants were issued as part of a unit, with each unit consisting of one share of Series C Convertible Preferred Stock and 575 Warrants"}],"balance_after":1725,"derivative":{"exercise_price":1.55,"exercise_date":"2018-07-03","expiration_date":"2023-07-03","underlying":"Common Stock","underlying_shares":1725},"source":{"system":"sec-edgar","filing":"0001104659-18-043792","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1276551/000110465918043792/a4.xml","form_type":"4"}},{"id":3874333,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":25396,"kind":"person","name":"BRANCACCIO JOHN P","position":1,"cik":"0001276551","reported_name":"BRANCACCIO JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series C Convertible Preferred Stock","published_at":"2018-07-03T18:16:44.000Z","date":"2018-07-03","kind":"purchase","acquired":true,"shares":3,"price":1000,"value":3000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series C Convertible Preferred Stock is convertible into the number of shares of Common Stock equal to the stated value of $1,000 divided by $1.55."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Shares of Series C Convertible Preferred Stock and Warrants were issued as part of a unit, with each unit consisting of one share of Series C Convertible Preferred Stock and 575 Warrants"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Shares of Series C Convertible Preferred Stock do not expire."}],"balance_after":3,"derivative":{"exercise_price":1.55,"exercise_date":"2018-07-03","underlying":"Common Stock","underlying_shares":1936},"source":{"system":"sec-edgar","filing":"0001104659-18-043792","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1276551/000110465918043792/a4.xml","form_type":"4"}},{"id":3888234,"issuer":{"id":164269,"kind":"organization","name":"SYNERGY PHARMACEUTICALS, INC.","symbol":"SGYP"},"owners":[{"id":25396,"kind":"person","name":"BRANCACCIO JOHN P","position":1,"cik":"0001276551","reported_name":"BRANCACCIO JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2018-06-19T20:30:22.000Z","date":"2018-06-16","kind":"grant","acquired":true,"shares":114750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the annual grant of stock options to each outside independent board member of the issuer."}],"balance_after":556196,"derivative":{"exercise_price":1.8,"exercise_date":"2019-06-16","expiration_date":"2028-06-16","underlying":"Common Stock","underlying_shares":114750},"source":{"system":"sec-edgar","filing":"0001104659-18-041061","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1276551/000110465918041061/a4.xml","form_type":"4"}},{"id":3895185,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":25396,"kind":"person","name":"BRANCACCIO JOHN P","position":1,"cik":"0001276551","reported_name":"BRANCACCIO JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-14T00:40:38.000Z","date":"2018-06-08","kind":"purchase","acquired":true,"shares":10000,"price":0.8,"value":8000.0,"ownership":{"direct":true},"balance_after":13598,"source":{"system":"sec-edgar","filing":"0000899243-18-016465","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000089924318016465/doc4a.xml","form_type":"4/A","original_submission_date":"2018-06-11"}},{"id":3898135,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":25396,"kind":"person","name":"BRANCACCIO JOHN P","position":1,"cik":"0001276551","reported_name":"BRANCACCIO JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-11T10:03:40.000Z","date":"2018-06-08","kind":"purchase","acquired":true,"shares":10000,"price":0.8,"value":8000.0,"ownership":{"direct":true},"balance_after":53167,"source":{"system":"sec-edgar","filing":"0000899243-18-015836","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000089924318015836/doc4.xml","form_type":"4"}},{"id":3976095,"issuer":{"id":164269,"kind":"organization","name":"SYNERGY PHARMACEUTICALS, INC.","symbol":"SGYP"},"owners":[{"id":25396,"kind":"person","name":"BRANCACCIO JOHN P","position":1,"cik":"0001276551","reported_name":"BRANCACCIO JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2018-04-02T21:00:54.000Z","date":"2018-04-02","kind":"exercise","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options became exercisable on 7/9/2009 and 7/9/2010."}],"balance_after":441446,"derivative":{"exercise_price":0.5,"expiration_date":"2018-07-09","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001104659-18-021838","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1276551/000110465918021838/a4.xml","form_type":"4"}},{"id":3976094,"issuer":{"id":164269,"kind":"organization","name":"SYNERGY PHARMACEUTICALS, INC.","symbol":"SGYP"},"owners":[{"id":25396,"kind":"person","name":"BRANCACCIO JOHN P","position":1,"cik":"0001276551","reported_name":"BRANCACCIO JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-04-02T21:00:54.000Z","date":"2018-04-02","kind":"exercise","acquired":true,"shares":50000,"price":0.5,"value":25000.0,"ownership":{"direct":true},"balance_after":76944,"source":{"system":"sec-edgar","filing":"0001104659-18-021838","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1276551/000110465918021838/a4.xml","form_type":"4"}},{"id":4089569,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":25396,"kind":"person","name":"BRANCACCIO JOHN P","position":1,"cik":"0001276551","reported_name":"BRANCACCIO JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2018-01-25T22:05:13.000Z","date":"2018-01-23","kind":"grant","acquired":true,"shares":54322,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":246130,"derivative":{"exercise_price":0.3,"exercise_date":"2019-01-23","expiration_date":"2028-01-23","underlying":"Common Stock","underlying_shares":54322},"source":{"system":"sec-edgar","filing":"0000899243-18-001907","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000089924318001907/doc4.xml","form_type":"4"}},{"id":4107015,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":25396,"kind":"person","name":"BRANCACCIO JOHN P","position":1,"cik":"0001276551","reported_name":"BRANCACCIO JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-01-04T22:18:47.000Z","date":"2018-01-02","kind":"exercise","acquired":false,"shares":16667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit is the economic equivalent of one share of Trovagene, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On January 2, 2017, the reporting person was granted 16,667 restricted stock units, all of which vested on January 2, 2018. The common stock into which such vested restricted stock units converted on January 2, 2018 is reported in Table I on this Form 4."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On January 2, 2017, the reporting person was granted 16,667 restricted stock units, all of which vested on January 2, 2018. The common stock into which such vested restricted stock units converted on January 2, 2018 is reported in Table I on this Form 4."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":16667},"source":{"system":"sec-edgar","filing":"0000899243-18-000491","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000089924318000491/doc4.xml","form_type":"4"}},{"id":4107014,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":25396,"kind":"person","name":"BRANCACCIO JOHN P","position":1,"cik":"0001276551","reported_name":"BRANCACCIO JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-04T22:18:47.000Z","date":"2018-01-02","kind":"exercise","acquired":true,"shares":16667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the conversion upon vesting of restricted stock units into common stock (the \"Converted Common Stock\"). On January 2, 2017, the reporting person was granted 16,667 restricted stock units, all of which vested on January 2, 2018. Such restricted stock units were previously reported in Table II on a Form 4 filed with the Securities and Exchange Commission on January 5, 2017."}],"balance_after":43167,"source":{"system":"sec-edgar","filing":"0000899243-18-000491","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000089924318000491/doc4.xml","form_type":"4"}},{"id":4190850,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":25396,"kind":"person","name":"BRANCACCIO JOHN P","position":1,"cik":"0001276551","reported_name":"BRANCACCIO JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2017-10-05T20:18:58.000Z","date":"2017-10-04","kind":"grant","acquired":true,"shares":38106,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":191808,"derivative":{"exercise_price":0.72,"exercise_date":"2018-10-04","expiration_date":"2027-10-04","underlying":"Common Stock","underlying_shares":38106},"source":{"system":"sec-edgar","filing":"0001104659-17-061152","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000110465917061152/a4.xml","form_type":"4"}},{"id":4215748,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":25396,"kind":"person","name":"BRANCACCIO JOHN P","position":1,"cik":"0001276551","reported_name":"BRANCACCIO JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-09-07T00:41:14.000Z","date":"2017-09-02","kind":"exercise","acquired":false,"shares":12667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit is the economic equivalent of one share of Trovagene, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On January 2, 2017, the reporting person was granted 12,667 restricted stock units, all of which vested on September 2, 2017. The common stock into which such vested restricted stock units converted on September 2, 2017 is reported in Table I on this Form 4."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On January 2, 2017, the reporting person was granted 12,667 restricted stock units, all of which vested on September 2, 2017. The common stock into which such vested restricted stock units converted on September 2, 2017 is reported in Table I on this Form 4."}],"balance_after":16667,"derivative":{"underlying":"Common Stock","underlying_shares":12667},"source":{"system":"sec-edgar","filing":"0001104659-17-055890","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000110465917055890/a4.xml","form_type":"4"}},{"id":4215747,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":25396,"kind":"person","name":"BRANCACCIO JOHN P","position":1,"cik":"0001276551","reported_name":"BRANCACCIO JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-09-07T00:41:14.000Z","date":"2017-09-02","kind":"exercise","acquired":true,"shares":12667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the conversion upon vesting of restricted stock units into common stock (the \"Converted Common Stock\"). On January 2, 2017, the reporting person was granted 12,667 restricted stock units, all of which vested on September 2, 2017. Such restricted stock units were previously reported in Table II on a Form 4 filed with the Securities and Exchange Commission on January 5, 2017."}],"balance_after":26500,"source":{"system":"sec-edgar","filing":"0001104659-17-055890","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000110465917055890/a4.xml","form_type":"4"}},{"id":4269033,"issuer":{"id":164269,"kind":"organization","name":"SYNERGY PHARMACEUTICALS, INC.","symbol":"SGYP"},"owners":[{"id":25396,"kind":"person","name":"BRANCACCIO JOHN P","position":1,"cik":"0001276551","reported_name":"BRANCACCIO JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2017-06-30T21:08:23.000Z","date":"2017-06-28","kind":"grant","acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported transactions with this same footnote involved an amendment of an outstanding option, resulting in the deemed cancellation of the old option and the grant of a replacement option. The old option was originally granted on November 20, 2009. The vesting schedule of the old option was reported on a Form 3 filed by the reporting person on August 3, 2011."}],"balance_after":481372,"derivative":{"exercise_price":1.4,"exercise_date":"2017-06-28","expiration_date":"2019-11-20","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001104659-17-043010","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1276551/000110465917043010/a4.xml","form_type":"4"}},{"id":4269032,"issuer":{"id":164269,"kind":"organization","name":"SYNERGY PHARMACEUTICALS, INC.","symbol":"SGYP"},"owners":[{"id":25396,"kind":"person","name":"BRANCACCIO JOHN P","position":1,"cik":"0001276551","reported_name":"BRANCACCIO JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2017-06-30T21:08:23.000Z","date":"2017-06-28","kind":"disposition_to_issuer","acquired":false,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported transactions with this same footnote involved an amendment of an outstanding option, resulting in the deemed cancellation of the old option and the grant of a replacement option. The old option was originally granted on November 20, 2009. The vesting schedule of the old option was reported on a Form 3 filed by the reporting person on August 3, 2011."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reported transactions with this same footnote involved an amendment of an outstanding option, resulting in the deemed cancellation of the old option and the grant of a replacement option. The old option was originally granted on November 20, 2009. The vesting schedule of the old option was reported on a Form 3 filed by the reporting person on August 3, 2011."}],"balance_after":467372,"derivative":{"exercise_price":1.4,"expiration_date":"2019-11-20","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001104659-17-043010","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1276551/000110465917043010/a4.xml","form_type":"4"}},{"id":4269031,"issuer":{"id":164269,"kind":"organization","name":"SYNERGY PHARMACEUTICALS, INC.","symbol":"SGYP"},"owners":[{"id":25396,"kind":"person","name":"BRANCACCIO JOHN P","position":1,"cik":"0001276551","reported_name":"BRANCACCIO JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2017-06-30T21:08:23.000Z","date":"2017-06-28","kind":"grant","acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":481372,"derivative":{"exercise_price":4.5,"exercise_date":"2018-06-28","expiration_date":"2027-06-28","underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001104659-17-043010","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1276551/000110465917043010/a4.xml","form_type":"4"}},{"id":4301026,"issuer":{"id":164269,"kind":"organization","name":"SYNERGY PHARMACEUTICALS, INC.","symbol":"SGYP"},"owners":[{"id":25396,"kind":"person","name":"BRANCACCIO JOHN P","position":1,"cik":"0001276551","reported_name":"BRANCACCIO JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-30T11:56:03.000Z","date":"2017-05-26","kind":"purchase","acquired":true,"shares":6500,"price":3.59,"value":23335.0,"ownership":{"direct":true},"balance_after":30444,"source":{"system":"sec-edgar","filing":"0001104659-17-035885","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1276551/000110465917035885/a4.xml","form_type":"4"}},{"id":4497975,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":25396,"kind":"person","name":"BRANCACCIO JOHN P","position":1,"cik":"0001276551","reported_name":"BRANCACCIO JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-01-05T21:57:26.000Z","date":"2017-01-02","kind":"grant","acquired":true,"shares":12667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit is the economic equivalent of one share of Trovagene, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs shall vest on September 2, 2017."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs shall vest on September 2, 2017."}],"balance_after":29334,"derivative":{"underlying":"Common Stock","underlying_shares":12667},"source":{"system":"sec-edgar","filing":"0001104659-17-000962","document":"a4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000110465917000962/a4a.xml","form_type":"4/A","original_submission_date":"2017-01-04"}},{"id":4497974,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":25396,"kind":"person","name":"BRANCACCIO JOHN P","position":1,"cik":"0001276551","reported_name":"BRANCACCIO JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-01-05T21:57:26.000Z","date":"2017-01-02","kind":"grant","acquired":true,"shares":16667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit is the economic equivalent of one share of Trovagene, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs shall vest on January 2, 2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs shall vest on January 2, 2018."}],"balance_after":16667,"derivative":{"underlying":"Common Stock","underlying_shares":16667},"source":{"system":"sec-edgar","filing":"0001104659-17-000962","document":"a4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000110465917000962/a4a.xml","form_type":"4/A","original_submission_date":"2017-01-04"}},{"id":4501968,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":25396,"kind":"person","name":"BRANCACCIO JOHN P","position":1,"cik":"0001276551","reported_name":"BRANCACCIO JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-01-04T22:00:42.000Z","date":"2017-01-02","kind":"grant","acquired":true,"shares":16667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit is the economic equivalent of one share of Trovagene, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs shall vest on January 2, 2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs shall vest on January 2, 2018."}],"balance_after":16667,"derivative":{"underlying":"Common Stock","underlying_shares":16667},"source":{"system":"sec-edgar","filing":"0001104659-17-000627","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000110465917000627/a4.xml","form_type":"4"}},{"id":4597818,"issuer":{"id":164269,"kind":"organization","name":"SYNERGY PHARMACEUTICALS, INC.","symbol":"SGYP"},"owners":[{"id":25396,"kind":"person","name":"BRANCACCIO JOHN P","position":1,"cik":"0001276551","reported_name":"BRANCACCIO JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2016-09-21T20:31:48.000Z","date":"2016-09-19","kind":"exercise","acquired":false,"shares":1079,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully vested."}],"balance_after":418872,"derivative":{"exercise_price":4.28,"expiration_date":"2016-10-12","underlying":"Common Stock","underlying_shares":1079},"source":{"system":"sec-edgar","filing":"0001104659-16-145907","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1276551/000110465916145907/a4.xml","form_type":"4"}},{"id":4597817,"issuer":{"id":164269,"kind":"organization","name":"SYNERGY PHARMACEUTICALS, INC.","symbol":"SGYP"},"owners":[{"id":25396,"kind":"person","name":"BRANCACCIO JOHN P","position":1,"cik":"0001276551","reported_name":"BRANCACCIO JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2016-09-21T20:31:48.000Z","date":"2016-09-19","kind":"exercise","acquired":false,"shares":1439,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully vested."}],"balance_after":419951,"derivative":{"exercise_price":4.61,"expiration_date":"2016-10-19","underlying":"Common Stock","underlying_shares":1439},"source":{"system":"sec-edgar","filing":"0001104659-16-145907","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1276551/000110465916145907/a4.xml","form_type":"4"}},{"id":4597816,"issuer":{"id":164269,"kind":"organization","name":"SYNERGY PHARMACEUTICALS, INC.","symbol":"SGYP"},"owners":[{"id":25396,"kind":"person","name":"BRANCACCIO JOHN P","position":1,"cik":"0001276551","reported_name":"BRANCACCIO JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-09-21T20:31:48.000Z","date":"2016-09-19","kind":"sale","acquired":false,"shares":2518,"price":5.76,"value":14503.68,"ownership":{"direct":true},"balance_after":20444,"source":{"system":"sec-edgar","filing":"0001104659-16-145907","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1276551/000110465916145907/a4.xml","form_type":"4"}},{"id":4597815,"issuer":{"id":164269,"kind":"organization","name":"SYNERGY PHARMACEUTICALS, INC.","symbol":"SGYP"},"owners":[{"id":25396,"kind":"person","name":"BRANCACCIO JOHN P","position":1,"cik":"0001276551","reported_name":"BRANCACCIO JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-09-21T20:31:48.000Z","date":"2016-09-19","kind":"exercise","acquired":true,"shares":1079,"price":4.28,"value":4618.12,"ownership":{"direct":true},"balance_after":22962,"source":{"system":"sec-edgar","filing":"0001104659-16-145907","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1276551/000110465916145907/a4.xml","form_type":"4"}},{"id":4597814,"issuer":{"id":164269,"kind":"organization","name":"SYNERGY PHARMACEUTICALS, INC.","symbol":"SGYP"},"owners":[{"id":25396,"kind":"person","name":"BRANCACCIO JOHN P","position":1,"cik":"0001276551","reported_name":"BRANCACCIO JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-09-21T20:31:48.000Z","date":"2016-09-19","kind":"exercise","acquired":true,"shares":1439,"price":4.61,"value":6633.79,"ownership":{"direct":true},"balance_after":21883,"source":{"system":"sec-edgar","filing":"0001104659-16-145907","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1276551/000110465916145907/a4.xml","form_type":"4"}}]}